methotrexate has been researched along with Fibroadenoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Endo, Y; Hanasawa, K; Kushima, R; Naitoh, H; Tani, T | 1 |
| Klaamas, K; Kurtenkov, O; Miljukhina, L; Rittenhouse-Olson, K; Sergejev, B; Shljapnikova, L; Vahter, L | 1 |
1 review(s) available for methotrexate and Fibroadenoma
| Article | Year |
|---|---|
Invasive ductal carcinoma within a fibroadenoma of the breast.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Female; Fibroadenoma; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Treatment Outcome | 2004 |
1 other study(ies) available for methotrexate and Fibroadenoma
| Article | Year |
|---|---|
IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
Topics: Adult; Aged; Aged, 80 and over; alpha-Galactosidase; Antibodies, Neoplasm; Antibody Formation; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epitopes; Female; Fibroadenoma; Fluorouracil; Haptens; Humans; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Rate; Thromboplastin | 2005 |